ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

FGEN FibroGen Inc

1,1982
-0,0718 (-5,65%)
19 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
FibroGen Inc FGEN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0718 -5,65% 1,1982 00:30:06
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,27 1,14 1,29 1,17 1,27
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.4.202423:46GLOBEFibroGen Announces Topline Results from Phase 1 Monotherapy..
26.3.202412:00GLOBEFibroGen to Present at 23rd Annual Needham Virtual..
11.3.202412:00GLOBEFibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
09.3.202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.3.202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.3.202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:08EDGAR2Form 8-K - Current report
26.2.202422:06GLOBEFibroGen Reports Fourth Quarter and Full Year 2023 Financial..
26.2.202422:05GLOBEFibroGen Regains All Rights to Roxadustat from AstraZeneca..
24.2.202402:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.2.202402:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.2.202402:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202413:00GLOBEFibroGen to Report Fourth Quarter and Full Year 2023..
14.2.202421:37EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06.2.202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202413:00GLOBEFibroGen To Host Part I of Virtual KOL Investor Event Series..
25.1.202413:00GLOBEFibroGen Announces Completion of the Pamrevlumab Arm in..
27.12.202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.12.202323:02GLOBEFibroGen Presents Data from Phase 3 MATTERHORN Trial of..
06.11.202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202322:05EDGAR2Form 8-K - Current report
06.11.202322:01GLOBEFibroGen Reports Third Quarter 2023 Financial Results
03.11.202321:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.10.202322:30EDGAR2Form 8-K - Current report
23.10.202313:00GLOBEFibroGen to Report Third Quarter 2023 Financial Results
26.9.202301:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202322:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202302:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202302:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202314:55EDGAR2Form 8-K - Current report
02.9.202301:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.9.202301:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.9.202323:31EDGAR2Form 144 - Report of proposed sale of securities
29.8.202323:14EDGAR2Form 8-K - Current report
29.8.202322:15GLOBEFibroGen Announces Topline Results from LELANTOS-2, a Phase..
14.8.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202301:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.8.202322:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.8.202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202322:06EDGAR2Form 8-K - Current report
07.8.202322:01GLOBEFibroGen Reports Second Quarter 2023 Financial Results
04.8.202322:42EDGAR2Form 144 - Report of proposed sale of securities
25.7.202314:32EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock